Zydus signs MoU with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection test in India: Our Bureau, Mumbai Saturday, July 4, 2026, 11:45 Hrs [IST] Zydus Lifesci ...
Men often learn to live with discomfort. A little back pain, getting up twice at night to use the washroom, or a weak urine ...
Zydus and Apollo Hospitals collaborate to enhance access to a multi-cancer blood test for early detection in India.
Prostate health awareness helps men identify early signs, understand risks, and navigate PSA tests and screening with trusted ...
Bladder cancer remains one of the most frequently diagnosed urologic malignancies worldwide, imposing a heavy and persistent ...
June 2026 Enhertu approved in the EU as first tumour agnostic HER2-directed therapy and antibody drug conjugate for patients with previously treated HER2-positive metastatic solid tumours Based on ...
NCCN now recognizes personalized, tumor-informed ctDNA-MRD as a prognostic and predictive biomarker in MIBC, extending ...
A study of the Galleri multicancer early detection test did not meet its primary endpoint of reducing the detection of ...
The Hearty Soul on MSN
What are the symptoms of prostate cancer and what should you check for?
Know the 8 prostate cancer symptoms to watch for, from urinary changes to bone pain, plus who is most at risk and when to get ...
The Man Who Died Twice is the name of a novel but it could be the title of a Jeremy Clarkson memoir. In less than 12 months, ...
The guidelines state that a test must be FDA-approved, personalized, tumor-informed, multiplex, and use PCR-NGS for ctDNA.
Unfortunately, Grail had bad news for investors in February when it released top-line results from the NHS and outlined that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results